title: [Expert meeting chronic obstructive airway disease--cardiovascular aspects of COPD].
abstract: This overview presents data that take advantage of a new step of insight into COPD. Large population-based retrospective studies and intensively investigated prospective cohorts are two important sources of knowledge that have been recently developed. One of the contributions introduces the German COSYCONET which is on its way shortly after the American ECLIPSE cohort. The vast amount of new data has also contributed to some corrections of the recommendations of the international GOLD committee. Clinically important are the waiver of the reversibility test for the diagnosis of COPD, the inclusion of sympotom scores to evaluate quality of life and the estimation of exacerbations. The COPD types I through IV were originally the result of expert opinion, but their impact on prognosis has recently been evaluated empirically.The top issues of the expert meeting were cardiovascular aspects of COPD. Besides the comorbidity of two significant chronic diseases, it became clear that cardiovascular events have an outstanding significance for COPD patients. Inversely, advanced COPD is an important risk factor in cardiac and vascular diseases. The mutual influence of both disease entities does not only affect the long term progression but also the outcome of acute events like myocardial infarction and COPD exacerbation. The following contributions investigate the topic with regard to epidemiology, the biology of vessels, and especially with regard to acute COPD exacerbations and pharmakotherapy. Recent evidence enables a fresh view on the cardiovascular toxicity of COPD medication and on possible protective effects of cardiovascular drugs (i.e. statins and ß-receptor antagonists) for patients with COPD.
authors.affiliation: Klinik für Pneumologie und Internistische Intensivmedizin, Klinikum Lüdenscheid.
authors.forename: J
authors.initials: J
authors.lastname: Lorenz
authors.forename: R
authors.initials: R
authors.lastname: Bals
authors.forename: H
authors.initials: H
authors.lastname: Magnussen
authors.forename: M
authors.initials: M
authors.lastname: Pfeifer
authors.forename: W
authors.initials: W
authors.lastname: Randerath
authors.forename: G
authors.initials: G
authors.lastname: Steinkamp
authors.forename: C
authors.initials: C
authors.lastname: Taube
authors.forename: H
authors.initials: H
authors.lastname: Teschler
authors.forename: C
authors.initials: C
authors.lastname: Vogelmeier
authors.forename: T
authors.initials: T
authors.lastname: Welte
authors.forename: H
authors.initials: H
authors.lastname: Worth
mesh_terms: D002309:Cardiology / Q000592:standards*; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D005858:Germany; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D015272:Pulmonary Medicine / Q000592:standards*